Stenocare A/S (FRA:S7C)

Market Cap	5.89M +431.6%
Revenue (ttm)	940.09K +214.5%
Net Income	-320.08K
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	28
Open	0.1365
Previous Close	0.1395
Day's Range	0.1355 - 0.1365
52-Week Range	0.0358 - 0.3460
Beta	n/a
RSI	52.05
Earnings Date	May 7, 2026

About Stenocare

Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. It offers medical cannabis oil products, including THC, THC/CBD, and CBD oil products. The company was incorporated in 2017 and is based in Randers, Denmark.

• Industry: Pharmaceutical Preparations
• Founded: 2017
• Employees: 8
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: S7C

Financial Performance

In 2025, Stenocare's revenue was 7.02 million, an increase of 214.54% compared to the previous year's 2.23 million. Losses were -2.39 million, -93.07% less than in 2024.

Financial numbers in DKK